CQ9: (3~{R},3'~{S})-4-methyl-3'-phenyl-spiro[1~{H}-1,4-benzodiazepine-3,2'-oxirane]-2,5-dione
CQ9 is a Ligand Of Interest in 6K0F designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6K0F_CQ9_B_403 | 43% | 7% | 0.136 | 0.86 | 1.97 | 2.76 | 5 | 10 | 0 | 0 | 100% | 1 |
| 6JZM_CQ9_B_403 | 55% | 0% | 0.128 | 0.897 | 8.66 | 3.11 | 6 | 8 | 0 | 0 | 100% | 1 |
